XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice

Prospective Registry of Patients Over 75 Years Old Treated With Xience Sierra Stents. Sierra 75 Study

NCT03567733 ·Status: COMPLETED

Diffuse Type In-Stent Restenosis After Drug-Eluting Stent

NCT00485030 ·Status: COMPLETED ·Phase: PHASE4

Alpine vs. Xpedition: Evaluation of Stent Delivery System

NCT03451617 ·Status: UNKNOWN ·Phase: NA

Xience Versus Synergy in Left Main PCI

NCT02303717 ·Status: UNKNOWN ·Phase: NA

Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO)

NCT01078051 ·Status: TERMINATED ·Phase: PHASE4

XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS)

NCT02513732 ·Status: COMPLETED

EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease

NCT01310309 ·Status: COMPLETED

Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary Artery Stenosis (PRE-COMBAT 2)

NCT01348022 ·Status: COMPLETED

Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period

NCT00882219 ·Status: COMPLETED ·Phase: PHASE3

Xience or Vision Stent Management of Angina in the Elderly

NCT02198716 ·Status: COMPLETED ·Phase: NA

Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions

NCT07190690 ·Status: RECRUITING ·Phase: NA

Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME)

NCT01348399 ·Status: COMPLETED

Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents

NCT04475380 ·Status: COMPLETED

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-VII: Sirolimus-eluting (Ultimaster) vs. Everolimus-Eluting Stents (Xience)

NCT03484234 ·Status: TERMINATED ·Phase: NA

Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late Loss After Stenting

NCT00960648 ·Status: COMPLETED

XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)

NCT01120379 ·Status: COMPLETED

LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery)

NCT01489761 ·Status: TERMINATED ·Phase: PHASE4

Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent

NCT05044273 ·Status: RECRUITING

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study

NCT01249027 ·Status: COMPLETED

Performance of Bioabsorbable Vascular Scaffolds (Absorb) Compared to Xience Stents - an Optical Coherence Tomography Study

NCT02001025 ·Status: UNKNOWN

Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome

NCT05965453 ·Status: RECRUITING

EXCEL Clinical Trial

NCT01205776 ·Status: COMPLETED ·Phase: NA

DESyne in Routine Clinical Practice

NCT02039713 ·Status: TERMINATED

XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE PRIME SV Japan PMS)

NCT02513719 ·Status: COMPLETED

The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente

NCT01066650 ·Status: COMPLETED ·Phase: PHASE4